Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Glaukos Corporation (GKOS) is a company in the Health care sector; its shares trade on NYSE.
The price of Glaukos Corporation (GKOS) on November 10, 2026 is 239.54 $, +0.34 % on the day. Over 52 weeks the stock traded between 80.91 $ and 255.19 $; the price now sits 91 % of the way up that range. Over the past year the price changed by +160.79 %. Market capitalization is 14.10 billion $, rank 10 among 103 stocks of the same industry with a known capitalization.
Glaukos Corporation trades on NYSE under the ticker GKOS. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks GKOS has traded between 80.91 $ and 255.19 $. As of 10 November 2026 the price stood 79.80% of the way from the 52-week low to the high.
Over one year GKOS shares rose 160.79%; over six months they rose 63.98%. Volatility over 90 days is 64.59%. Dividends are not included: this is price change only, as of 10 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 23.0, above the sector median of 3.7. Price to book is 20.7, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Glaukos Corporation reported revenue of 613M $ and a net loss of 188M $ over the last four quarters. Net margin is −30.68%. Revenue changed by +41.55% year over year. Earnings per share are −$3.27. Market capitalisation is 14.1B $.
GKOS has a return on equity of −27.55%, above the sector median of −40.58%. Return on assets is −20.43%, above the sector median of −30.08%. Operating margin is −31.55%, below the sector median of −20.96%.